🇺🇸 FDA

Intelligence · Clinical Pipeline

BRIGHT MINDS BIOSCIENCES Pipeline

All ClinicalTrials.gov programs at BRIGHT MINDS BIOSCIENCES — phase, modality, and trial IDs.

Programs
327

Quick answer

BRIGHT MINDS BIOSCIENCES has 327 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Fexofenadine Hydrochloride without sodium lauryl sulfate

    BRIGHT MINDS BIOSCIENCES INC.

    The Impact of Excipients on Drug Absorption

    phase 1 small molecule completed

    1 trial

  2. Fimasartan

    BRIGHT MINDS BIOSCIENCES INC.

    Hypertension

    phase 1 small molecule completed

    1 trial

  3. Four naloxone nasal spray doses (1 every 2.5 min)

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  4. G207

    BRIGHT MINDS BIOSCIENCES INC.

    Supratentorial Neoplasms, Malignant

    phase 1 mab completed

    1 trial

  5. GBR 12909

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 1 small molecule active

    3 trials

  6. GZ17-6.02

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  7. Gonadorelin

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 1 other completed

    1 trial

  8. HRG80™ Red Ginseng + gamma cyclodextrin

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Absorption

    phase 1 other on hold

    1 trial

  9. HW071021 Tablets

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  10. HW201877 capsules

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Participants

    phase 1 small molecule active

    1 trial

  11. HWS116 Injection

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  12. Health Promotion and Education

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking-Related Carcinoma

    phase 1 other completed

    1 trial

  13. Hydrocodone Bitartrate

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule active

    1 trial

  14. Hydrocortisone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule active

    1 trial

  15. INDV-2000

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  16. ITI-333

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  17. Ibudilast 20mg

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine-dependence

    phase 1 small molecule completed

    1 trial

  18. Inactive Marijuana (0% THC)

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Use Disorder

    phase 1 small molecule completed

    1 trial

  19. Incentives for being tobacco free

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Prevention and Cessation

    phase 1 other completed

    1 trial

  20. Individualized caffeine cessation instructions

    BRIGHT MINDS BIOSCIENCES INC.

    Self-identified Problematic Caffeine Use

    phase 1 other completed

    1 trial

  21. Interferon beta-1a

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Subjects

    phase 1 mab completed

    1 trial

  22. Isradipine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 small molecule completed

    1 trial

  23. JDtic

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule terminated

    1 trial

  24. KNX100

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  25. Kindolor Tosylate

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 1 small molecule terminated

    1 trial

  26. L-dopa / carbidopa / entacapone (LCE)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Abuse

    phase 1 small molecule completed

    1 trial

  27. Lamotrigine Extended Release

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  28. Lenalidomide (CC-5013)

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  29. Levodopa Cyclops®

    BRIGHT MINDS BIOSCIENCES INC.

    Parkinson

    phase 1 other completed

    1 trial

  30. Lidocaine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Heat Effect

    phase 1 small molecule completed

    1 trial

  31. Lifestyle counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Adherence

    phase 1 other completed

    1 trial

  32. Lobeline

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 1 small molecule active

    1 trial

  33. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Related Disorders

    phase 1 small molecule terminated

    1 trial

  34. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  35. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 1 small molecule completed

    1 trial

  36. Lofexidine (granules for reconstitution)

    BRIGHT MINDS BIOSCIENCES INC.

    Normal Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  37. Lofexidine HCl

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  38. Lofexidine hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Normal Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  39. Lofexidine hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Normal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the Product

    phase 1 small molecule completed

    1 trial

  40. Lopinavir/Ritonavir 200 mg/50 mg Film Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  41. Lorcaserin

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    1 trial

  42. MCAM

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule active

    1 trial

  43. MDMA

    BRIGHT MINDS BIOSCIENCES INC.

    MDMA ('Ecstasy')

    phase 1 small molecule completed

    1 trial

  44. MDMA

    BRIGHT MINDS BIOSCIENCES INC.

    Metabolism

    phase 1 small molecule completed

    1 trial

  45. Marijuana

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule completed

    1 trial

  46. Marijuana via vape device

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking-Related Carcinoma

    phase 1 small molecule active

    1 trial

  47. Marinol 10Mg Capsule TMS Sham

    BRIGHT MINDS BIOSCIENCES INC.

    Neurosciences

    phase 1 small molecule completed

    1 trial

  48. Medium THC

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Impairment

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does BRIGHT MINDS BIOSCIENCES have?

327 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.